1. Home
  2. MDV vs MOLN Comparison

MDV vs MOLN Comparison

Compare MDV & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Modiv Industrial Inc. Class C

MDV

Modiv Industrial Inc. Class C

HOLD

Current Price

$15.04

Market Cap

157.4M

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.57

Market Cap

158.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDV
MOLN
Founded
2015
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Transportation Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
157.4M
158.9M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
MDV
MOLN
Price
$15.04
$4.57
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$8.38
AVG Volume (30 Days)
35.2K
6.8K
Earning Date
03-03-2026
03-05-2026
Dividend Yield
7.89%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$47,479,000.00
N/A
Revenue This Year
$0.13
N/A
Revenue Next Year
$0.71
$999.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.62
$3.36
52 Week High
$17.15
$5.15

Technical Indicators

Market Signals
Indicator
MDV
MOLN
Relative Strength Index (RSI) 56.05 60.98
Support Level $14.93 $4.01
Resistance Level $15.51 $4.28
Average True Range (ATR) 0.34 0.18
MACD 0.04 0.05
Stochastic Oscillator 65.22 70.59

Price Performance

Historical Comparison
MDV
MOLN

About MDV Modiv Industrial Inc. Class C

Modiv Industrial Inc is a pioneer in the direct-to-consumer commercial real estate product industry. It provides individual investors access to real estate and real estate-related investments designed to provide both income and long-term growth. The Company has invested in single-tenant income-producing properties. Its current business consists of owning, managing, operating, leasing, acquiring, investing in and disposing of commercial real estate assets utilized for industrial manufacturing, as well as a few non-core assets. All of the company's consolidated revenues are derived from company's consolidated real estate properties.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: